A unique opportunity to acquire a diversified, vertically integrated cannabis group comprising:

• A 30-year legacy Dutch seed bank and global genetics brand
• A centrally located Amsterdam retail store and international e-commerce platform
• A fully licensed 1.5-hectare Colombian cultivation and export operation

Note: Each business can also be acquired separately.

Amsterdam Legacy Cannabis Genetics Brand

A 100% equity acquisition of a pioneering Dutch seed bank with over 30 years of operational history. The transaction includes all intellectual property and operational assets, including genetics, tissue culture IP, breeder’s rights, contracts, packaged and unpackaged inventory, breeder stock, equipment, trade show assets, digital infrastructure (websites and domains), systems, processes, brand assets, and the full team.

The headquarters are located at Hoogoorddreef 103, Amsterdam, leased from the holding structure (Internature B.V.) at a fair market rent of €2,750/month.

This is a globally recognized cannabis genetics brand with a portfolio of 40+ developed cultivars, a proprietary genetic library in seeds and tissue culture, and over 50 international awards. The company also holds multiple CPVO registrations.

The business generates consistent annual revenues of approximately €1.1–1.5 million, derived from a diversified mix of B2B wholesale, medical genetics licensing, and direct-to-consumer e-commerce. It maintains established relationships with leading international distributors and long-term licensing agreements with global medical cannabis producers.

Amsterdam Retail & E-Commerce Business

An asset sale including all digital infrastructure (websites and domains), inventory, equipment (including office hardware and retail fixtures), and operational team.

The retail location at Gravenstraat 12, Amsterdam is leased from a neighbouring hotel operator (P en E Hotels) at a monthly rent of €3,569.50.

This centrally located retail store and global e-commerce platform specializes in cannabis seeds and related products. The business generates approximately €1.0–1.4 million in annual revenue, split evenly between international online sales and physical retail traffic.

It represents one of Amsterdam’s largest curated cannabis seed inventories and serves as a direct-to-consumer commercialization channel for genetics and brand equity. The operation is currently under-optimized, presenting clear opportunities for digital scaling, margin improvement, and operational efficiency—particularly through integration with its affiliated genetics brand.

Colombian Licensed Cultivation & Export Platform

A fully licensed cultivation and export platform in Colombia with a complete operational ecosystem. The sale includes a multidisciplinary local team comprising legal counsel, accounting, COO, legal representative, agronomist, and administrative staff.

Key structural components include a lease agreement with purchase option, 250 ICA-registered varieties, and a full suite of regulatory licenses:

• License to produce and export seeds
• Psychoactive cultivation and export license (high-THC flower)
• Non-psychoactive cultivation and export license (CBD/hemp)
• Manufacturing license for derivatives and exports
• Research license for natural health products (NHPs)

This platform provides a fully compliant, scalable production and export base for both medical and wellness cannabis product lines.